← Home UAE · nd-uae

BeOne Medicines Highlights Rapidly Accelerating Solid Tumor Franchise at ESMO 2026>

Source: aetoswire · 2026-10-18T18:30:00 UTC

(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that data from across its rapidly progressing solid tumor portfolio will be presented at the European Society for Medical Oncology (ESMO) Congress 2026 on October 23-27 in Madrid. Presentations will highlight an accelerating pipeline of differentiated targeted therapies, alongs

Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.

Read full story on publisher site →

BeOne Medicines Highlights Rapidly Accelerating Solid Tumor Franchise at ESMO 2026>

Related in UAE

Asian cultural heritage alliance adds Egypt as partner, Kazakhstan as observer

Araghchi says 7-day plan to reopen Hormuz Strait still on table

IRGC reports oil supertanker, carrying 2 million barrels of crude, 'hit a mine' while sailing an 'unauthorised' route off Oman

Together, We Transform 60+: Alpro Group Advance Early Thyroid Detection for Ageing Malaysians

Bahrain braces for money laundering watchdog review

Cartoon for October 19, 2026